BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17591307)

  • 1. A campaign worth joining: improving outcome in severe sepsis and septic shock using the Surviving Sepsis Campaign guidelines.
    Patel GP; Elpern EH; Balk RA
    South Med J; 2007 Jun; 100(6):557-8. PubMed ID: 17591307
    [No Abstract]   [Full Text] [Related]  

  • 2. Recognizing and managing severe sepsis: a common and deadly threat.
    Schlichting D; McCollam JS
    South Med J; 2007 Jun; 100(6):594-600. PubMed ID: 17591313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of clinicians addressing the approach to the management of severe sepsis and septic shock in the United States.
    Djurkovic S; Baracaldo JC; Guerra JA; Sartorius J; Haupt MT
    J Crit Care; 2010 Dec; 25(4):658.e1-6. PubMed ID: 20646900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of neonatal sepsis and septic shock].
    Wojsyk-Banaszak I; Szczapa J
    Przegl Epidemiol; 2006; 60(1):119-26. PubMed ID: 16758750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New clinical practice guidelines of the surviving sepsis campaign: a critical appraisal.
    Palencia Herrejón E; Bueno García B
    Med Intensiva; 2013 Dec; 37(9):600-4. PubMed ID: 24119680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock.
    Osborn TM; Nguyen HB; Rivers EP
    Ann Emerg Med; 2005 Sep; 46(3):228-31. PubMed ID: 16126131
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing, treating and managing patients with sepsis.
    Robson W; Newell J
    Nurs Stand; 2005 Aug 24-30; 19(50):56-64. PubMed ID: 16138619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis].
    Aikawa N
    Jpn J Antibiot; 2011 Feb; 64(1):37-44. PubMed ID: 21786480
    [No Abstract]   [Full Text] [Related]  

  • 9. Feasibility of introduction and implementation of the Surviving Sepsis Campaign bundle in a Singapore emergency department.
    Kuan WS; Mahadevan M; Tan JH; Guo J; Ibrahim I
    Eur J Emerg Med; 2013 Oct; 20(5):344-9. PubMed ID: 23211272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated review of sepsis for the anesthesiologist.
    Tzimas KN; Papadakos PJ
    Semin Cardiothorac Vasc Anesth; 2013 Dec; 17(4):262-8. PubMed ID: 24013953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing mortality in severe sepsis: the Surviving Sepsis Campaign.
    Townsend SR; Schorr C; Levy MM; Dellinger RP
    Clin Chest Med; 2008 Dec; 29(4):721-33, x. PubMed ID: 18954706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of nuclear factor-κB in pathogenesis of severe sepsis and septic shock: possible mechanisms of gene therapy targeting inflammatory alert cells].
    Matsuda N
    Masui; 2009 Nov; 58 Suppl():S305-11. PubMed ID: 22685753
    [No Abstract]   [Full Text] [Related]  

  • 13. An audit of compliance with the sepsis resuscitation care bundle in patients admitted to A&E with severe sepsis or septic shock.
    Baldwin LN; Smith SA; Fender V; Gisby S; Fraser J
    Int Emerg Nurs; 2008 Oct; 16(4):250-6. PubMed ID: 18929343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation models for therapy planning/standardization exemplified by infection].
    Encke A; Hanisch E; Sitter H; Greger B; Bauhofer A; Margolis C; Lorenz W
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():323-9. PubMed ID: 9574147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic plasma exchange in severe sepsis or septic shock.
    Kes P
    Acta Med Croatica; 1998; 52(2):127-32. PubMed ID: 9682501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on "Surviving sepsis campaign guidelines for the management of severe sepsis and septic shock" by Dellinger et al.
    Zandstra DF; van der Voort PH
    Intensive Care Med; 2004 Oct; 30(10):1984; author reply 1981. PubMed ID: 15278271
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.
    Poulton B
    Int J Antimicrob Agents; 2006 Feb; 27(2):97-101. PubMed ID: 16417989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sepsis].
    Reinhart K; Brunkhorst FM
    Zentralbl Chir; 2002 Mar; 127(3):161-3. PubMed ID: 11935476
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation.
    Rivers EP; Ahrens T
    Crit Care Clin; 2008 Jul; 24(3 Suppl):S1-47. PubMed ID: 18634996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.